Australia Legal Cannabis Market

Publisher Grand View Research

Published Jul 23, 2025

Length 90 Pages

SKU # GV20303635

Description

Australia Legal Cannabis Market Summary

The Australia legal cannabis market size was estimated at USD 123.9 million in 2024 and is projected to reach USD 815.1 million by 2033, growing at a CAGR of 20.3% from 2025 to 2033. The industry is driven by growing awareness of the health benefits of cannabis and the growing legalization of marijuana, mostly for medical purposes.

Furthermore, the increase in medical marijuana output as a result of increasing demand in the pharmaceutical sector is boosting overall growth. For instance, in 2016, the Australian Government legalized cannabis for medicinal purposes in all six states and two territories. Furthermore, the Therapeutic Goods Administration (TGA) regulates the supply of medicinal products in Australia.

In Australia, the legal framework regulating medicinal cannabis is constantly evolving and remains closely monitored. New legislation was enacted by the Australian government, allowing the Australian Capital Territory (ACT) to acquire and cultivate four plants per household for personal use. In October 2023, the Australian Capital Territory (ACT) introduced certain regulations on the use of products such as marijuana and hemp. It stated that individuals over 18 years old can own cannabis (fresh up to 150 grams or dried up to 50 grams). This factor is expected to contribute to their usage in Australia.

Moreover, as per the March 2025 updates, the tax benefit of recreational products in Australia is expected to reach USD 700 million annually, which is aimed at having significant implications for the industry. This figure, highlighted by the Australian Greens as they renew their pledge to advocate for legalizing recreational cannabis, underscores both the economic potential and the shifting political landscape surrounding cannabis legislation in Australia. The estimated USD 700 million revenue can be allocated to various public services, including healthcare, education, and infrastructure. By legalization, governments can create a new stream of income that can help alleviate budgetary pressures.

Australia Legal Cannabis Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Australia legal cannabis market report based on sources, derivatives, and end use:

Sources Outlook (Revenue, USD Million, 2021 - 2033)
Marijuana
Flower
Oil and Tinctures
Hemp
Hemp CBD
Supplements
Industrial Hemp
Derivatives Outlook (Revenue, USD Million, 2021 - 2033)
CBD
THC
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Medical
Cancer
Chronic Pain
Depression and Anxiety
Arthritis
Diabetes
Glaucoma
Migraines
Epilepsy
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Alzheimer
Post Traumatic Stress Disorder (PTSD)
Parkinson's Disease
Tourette
Others
Recreational
Industrial

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.1.1. Segment scope; 1.1.2. Regional scope; 1.1.3. Estimates and forecast timeline; 1.2. Research Methodology; 1.3. Information Procurement; 1.3.1. Purchased database; 1.3.2. GVR’s internal database; 1.3.3. Secondary sources; 1.3.4. Primary research; 1.3.5. Details of primary research; 1.4. Information or Data Analysis; 1.4.1. Data analysis models; 1.5. Market Formulation & Validation; 1.6. Model Details; 1.6.1. Commodity flow analysis (Model 1); 1.6.1.1. Approach 1: Commodity flow approach; 1.7. Research Assumptions; 1.8. List of Secondary Sources; 1.9. List of Primary Sources; 1.10. Objectives
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.2.1. Sources outlook; 2.2.2. Derivatives outlook; 2.2.3. End use outlook; 2.3. Competitive Insights
Chapter 3. Australia Legal Cannabis Market Variables, Trends & Scope: 3.1. Market Lineage Outlook; 3.2. Parent Market Outlook; 3.3. Ancillary Market Outlook; 3.4. Market Dynamics; 3.4.1. Market driver analysis; 3.4.2. Market restraint analysis; 3.5. Australia Legal Cannabis Market Analysis Tools; 3.5.1. Industry Analysis - Porter’s Five Forces Analysis; 3.5.2. PESTEL Analysis; 3.6. Market Trends in the Country; 3.6.1. Introduction of New Cannabis Products; 3.6.2. Celebrity Cannabis Engagement; 3.6.3. Growing Popularity of Craft and Boutique Cannabis Brands; 3.6.4. Improved Cannabis Cultivation and Distribution Technology; 3.6.5. Federal and State Cannabis Policy Opportunities; 3.7. Regulatory Scenario in Australia; 3.8. Jurisdiction Analysis in Australia; 3.9. Cannabis Consumption Pattern Analysis, Australia; 3.10. Legal Cannabis Potential Trade Opportunity, Australia; 3.10.1. Global Legal Marijuana Trade Route; 3.10.2. Global Hemp Trade Route; 3.11. Legal Cannabis Seed to Shelf Story; 3.11.1. Section Description; 3.11.2. Cultivators & Growers; 3.11.3. Manufacturers & Producers; 3.11.4. Testers; 3.11.5. Wholesalers & Distributors; 3.11.6. Retailers; 3.11.7. Supply Chain Analysis; 3.11.8. Supply Chain Network from Hemp Cultivators to CBD Consumer Products; 3.11.9. Supply Chain Network of Hemp Biomass to Industrial Applications; 3.11.10. Supply Chain Network from Marijuana Plants to Marijuana Oil; 3.12. Profit Margin Analysis
Chapter 4. Australia Legal Cannabis Market: Sources, Estimates & Trend Analysis: 4.1. Definitions and Scope; 4.2. Sources Segment Dashboard; 4.3. Global Australia Legal Cannabis Market by Sources, 2021 to 2033; 4.4. Marijuana; 4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million); 4.4.2. Flower; 4.4.2.1. Market estimates and forecast, 2021 - 2033 (USD Million); 4.4.3. Oil and Tinctures; 4.4.3.1. Market estimates and forecast, 2021 - 2033 (USD Million); 4.5. Hemp; 4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million); 4.5.2. Hemp CBD; 4.5.2.1. Market estimates and forecast, 2021 - 2033 (USD Million); 4.5.3. Supplements; 4.5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million); 4.5.4. Industrial Hemp; 4.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 5. Australia Legal Cannabis Market: Derivatives Estimates & Trend Analysis: 5.1. Definitions and Scope; 5.2. Derivatives Segment Dashboard; 5.3. Global Australia Legal Cannabis Market by Derivatives, 2021 to 2033; 5.4. CBD; 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million); 5.5. THC; 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million); 5.6. Others; 5.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 6. Australia Legal Cannabis Market: End Use Estimates & Trend Analysis: 6.1. Definitions and Scope; 6.2. End Use Segment Dashboard; 6.3. Australia Legal Cannabis Market by End Use, 2021 to 2033; 6.4. Medical; 6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.2. Cancer; 6.4.2.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.3. Chronic Pain; 6.4.3.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.4. Depression and Anxiety; 6.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.5. Arthritis; 6.4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.6. Diabetes; 6.4.6.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.7. Glaucoma; 6.4.7.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.8. Migraines; 6.4.8.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.9. Epilepsy; 6.4.9.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.10. Multiple Sclerosis; 6.4.10.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.11. AIDS; 6.4.11.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.12. Amyotrophic Lateral Sclerosis; 6.4.12.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.13. Alzheimer; 6.4.13.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.14. Post Traumatic Stress Disorder (PTSD); 6.4.14.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.15. Parkinson's Disease; 6.4.15.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.16. Tourette; 6.4.16.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.4.17. Others; 6.4.17.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.5. Recreational; 6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million); 6.6. Industrial; 6.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape: 7.1. Recent Developments & Impact Analysis, By Key Market Participants; 7.2. Company/Competition Categorization; 7.3. Company Market Position Analysis; 7.4. Company Profiles; 7.4.1. Cann Group Limited; 7.4.1.1. Company overview; 7.4.1.2. Financial performance; 7.4.1.3. Product benchmarking; 7.4.1.4. Strategic initiatives; 7.4.2. Zelira Therapeutics; 7.4.2.1. Company overview; 7.4.2.2. Financial performance; 7.4.2.3. Product benchmarking; 7.4.2.4. Strategic initiatives; 7.4.3. AusCann Group Holdings Ltd.; 7.4.3.1. Company overview; 7.4.3.2. Financial performance; 7.4.3.3. Product benchmarking; 7.4.3.4. Strategic initiatives; 7.4.4. Bod Australia; 7.4.4.1. Company overview; 7.4.4.2. Financial performance; 7.4.4.3. Product benchmarking; 7.4.4.4. Strategic initiatives; 7.4.5. Althea Group; 7.4.5.1. Company overview; 7.4.5.2. Financial performance; 7.4.5.3. Product benchmarking; 7.4.5.4. Strategic initiatives; 7.4.6. ECOFIBRE; 7.4.6.1. Company overview; 7.4.6.2. Financial performance; 7.4.6.3. Product benchmarking; 7.4.6.4. Strategic initiatives; 7.4.7. Botanix Pharmaceuticals; 7.4.7.1. Company overview; 7.4.7.2. Financial performance; 7.4.7.3. Product benchmarking; 7.4.7.4. Strategic initiatives; 7.4.8. EPSILON; 7.4.8.1. Company overview; 7.4.8.2. Financial performance; 7.4.8.3. Product benchmarking; 7.4.8.4. Strategic initiatives; 7.4.9. Little Green Pharma; 7.4.9.1. Company overview; 7.4.9.2. Financial performance; 7.4.9.3. Product benchmarking; 7.4.9.4. Strategic initiatives; 7.4.10. Incannex; 7.4.10.1. Company overview; 7.4.10.2. Financial performance; 7.4.10.3. Product benchmarking; 7.4.10.4. Strategic initiatives

Pricing

Currency Rates

Single User Email from Publisher $3,500
Multi User License Fulfilled by Publisher $4,500
Global Site License Email from Publisher $6,500

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now